statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today...

MindMed to Participate in June Conferences

MindMed to Participate at May Investor Conferences

Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders...

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the 'Company' or 'MindMed'), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

MindMed Reports First Quarter 2024 Financial Results and Business Updates

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented...

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today...

MindMed to Present at Upcoming May Medical Conferences

Shares of Mind Medicine (MindMed) Inc. MNMD have skyrocketed 154% in the past three months against the industry's decline of 4.2%.The company is progressing well with the development of its lead...

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $11.85 and last traded at $11.69, with a...

Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 12-Month High at $11.85

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...

MindMed to Present at Upcoming April Medical Conferences

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.

Watchers	25,094
52-Wk Low	$2.41
52-Wk High	$12.22

Volume	157,900.00
52-Wk High	$12.22
52-Wk Low	$2.41

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.33	--	--	N/A
Q1'24	-$0.53	-$1.14	-115.68%	MISSED
Q4'23	-$0.46	-$0.58	-25.31%	MISSED
Q3'23	-$0.65	-$0.45	31.22%	BEAT
Q2'23	-$0.53	-$0.76	-42.44%	MISSED

MNMD Mind Medicine Inc - Ordinary Shares (Sub Voting)

About

Feed

News

Sentiment

Earnings

Fundamentals